Optimizing Treatment for ER+/HER2- mBC patients with aggressive disease
We are pleased to invite you for the next MBC TALKS webinar and live Q&A session where Prof. Gilles Freyer, Prof. Joyce A. O’Shaughnessy, Prof. Patrick Neven and Prof. Michael Untch will discuss different CDK4&6i data from both efficacy & safety stand point and how that can help improve patient outcome.
Agenda
Live Welcome & Introduction Gilles Freyer, France 5 min
Efficacy of Verzenios in endocrine resistant patients Joyce O’Shaughnessy, US 7 min
Live Q&A/Discussion All 5 min
Factors to consider for improving patient adherence Patrick Neven, Belgium 7 min
Live Q&A/Discussion All 5 min
Patient case 1 Michael Untch, Germany 7 min
Live Q&A/Discussion All 5 min
Patient case 2 Gilles Freyer, France 7 min
Live Q&A/Discussion All 5 min
Live Summary & Close Gilles Freyer, France 9 min
October 28th
Session time:
15:00 – 16:00 (CET)
19:00 – 20:00 (CET)
